Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
EXEL | EXELIXIS, INC. | President and CEO, Director | $81.2M | Nov 15, 2024 | ||
VERA | Vera Therapeutics, Inc. | Director | May 15, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|